Reports to Congress
- FY 2022 Device Pilot Projects
- FY 2021 Device Pilot Project
- FY 2020 Device Pilot Project
- FY 2019 Device Pilot Project
- FY 2017 Device Pilot Project
- Postmarket Device Safety-Related Communications Report to Congress
- FY 2019-FY 2020 Pediatric Report to Congress
- FY 2018 Pediatric Report to Congress
- FY 2017 Pediatric Report to Congress
- FY 2016 Pediatric Report to Congress
- FY 2015 Pediatric Report to Congress
- FY 2014 Pediatric Report to Congress
- FY 2013 Pediatric Report to Congress
- FY 2012 Pediatric Report to Congress
- FY 2009- 2011 Pediatric Report to Congress
- FY 2008 Pediatric Report to Congress
- Quality, Safety, and Effectiveness of Servicing of Medical Devices (FDARA 710) Report
- 2017 MQSA Report to Congress on Performance of Accreditation Bodies
- Report to Congress: Breakthrough Devices Program
- FDA Report to Congress: Least Burdensome Training Audit
- Report to Congress on FDA's Policy to be Proposed Regarding Premarket Notification Requirements for Modifications to Legally Marketed Devices
- A Federal Register notice on March 6, 2014, opened a public docket for comment on this report
- FDA Report to Congress: Improving the Prevention, Diagnosis, and Treatment of Rare and Neglected Diseases